Human Papillomavirus in Menstrual Blood

Completed

• Conditions: Human Papillomavirus
• Interventions: Other: Collecting a Pad used at the first menstrual period after enrollment

• Registration Number: NCT01506128
• Lead Sponsor: Seoul National University Hospital

Brief Summary

The investigators tried to know whether a virus causing cervical cancer could be detected in menstrual blood and to set up a experimental setting to detect the virus.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2012-01
• Study First Submitted: 2012-01-03
• Study First Submitted QC: 2012-01-04
• Study First Posted: 2012-01-09
• Primary Completion: 2013-01
• Study Completion: 2013-01
• Status Verified: 2013-03
• Last Update Submitted: 2013-03-04
• Last Update Posted: 2013-03-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 19

Inclusion Criteria

• Premenopausal women with HSIL at Pap test or high-risk HPV

Read More

Exclusion Criteria

• Suspicious cancer

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
HPV	Collecting a Pad used at the first menstrual period after enrollment	Premenopausal women with HSIL in Pap test or high-risk HPV

Primary Outcome Measures

Name	Time	Method
HPV detection rate in menstrual blood	First period after enrollment usually within 2 months after enrollment	The first menstrual period after enrollment is assumed to occur within 2 months. At that time, the participant used pads and send the used pads to investigators. The investigator do procedures to detect HPV in pads.

Trial Locations

Locations (1)

Seoul National University Bundang Hospital; 🇰🇷 Seongnam-si, Gyeonggi-do, Korea, Republic of